share_log

Recap: Atea Pharmaceuticals Q4 Earnings

要約:アテアファーマシューティカルズの第4四半期決算

Benzinga ·  02/28 16:35

Atea Pharmaceuticals (NASDAQ:AVIR) reported its Q4 earnings results on Wednesday, February 28, 2024 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Atea Pharmaceuticals beat estimated earnings by 6.0%, reporting an EPS of $-0.47 versus an estimate of $-0.5.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.08 which was followed by a 9.0% drop in the share price the next day.

To track all earnings releases for Atea Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする